These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

981 related articles for article (PubMed ID: 8828808)

  • 1. Comparison of the heparanase enzymes from mouse melanoma cells, mouse macrophages, and human platelets.
    Graham LD; Underwood PA
    Biochem Mol Biol Int; 1996 Jun; 39(3):563-71. PubMed ID: 8828808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that platelet and tumour heparanases are similar enzymes.
    Freeman C; Browne AM; Parish CR
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):361-8. PubMed ID: 10455023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
    J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelet heparanase: purification, characterization and catalytic activity.
    Freeman C; Parish CR
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1341-50. PubMed ID: 9494105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor metastasis-associated heparanase (heparan sulfate endoglycosidase) activity in human melanoma cells.
    Nakajima M; Irimura T; Nicolson GL
    Cancer Lett; 1986 Jun; 31(3):277-83. PubMed ID: 3719568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial purification of heparanase activities in Chinese hamster ovary cells: evidence for multiple intracellular heparanases.
    Bame KJ; Hassall A; Sanderson C; Venkatesan I; Sun C
    Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):191-200. PubMed ID: 9806900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
    Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
    Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of platelet heparanase during inflammation: role of pH and proteinases.
    Ihrcke NS; Parker W; Reissner KJ; Platt JL
    J Cell Physiol; 1998 Jun; 175(3):255-67. PubMed ID: 9572470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate endoglycosidase and metastatic potential in murine fibrosarcoma and melanoma.
    Ricoveri W; Cappelletti R
    Cancer Res; 1986 Aug; 46(8):3855-61. PubMed ID: 3731061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of basement membrane by prostate tumor heparanase.
    Kosir MA; Wang W; Zukowski KL; Tromp G; Barber J
    J Surg Res; 1999 Jan; 81(1):42-7. PubMed ID: 9889056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
    Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
    Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
    Irimura T; Nakajima M; Nicolson GL
    Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical localization of heparanase in mouse and human melanomas.
    Jin L; Nakajima M; Nicolson GL
    Int J Cancer; 1990 Jun; 45(6):1088-95. PubMed ID: 2351486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
    Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I
    Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D
    J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer.
    Fairbanks MB; Mildner AM; Leone JW; Cavey GS; Mathews WR; Drong RF; Slightom JL; Bienkowski MJ; Smith CW; Bannow CA; Heinrikson RL
    J Biol Chem; 1999 Oct; 274(42):29587-90. PubMed ID: 10514423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanases and tumor metastasis.
    Nakajima M; Irimura T; Nicolson GL
    J Cell Biochem; 1988 Feb; 36(2):157-67. PubMed ID: 3281960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of a rhamnogalacturonase with protopectinase activity from Trametes sanguinea.
    Sakamoto M; Shirane Y; Naribayashi I; Kimura K; Morishita N; Sakamoto T; Sakai T
    Eur J Biochem; 1994 Dec; 226(2):285-91. PubMed ID: 8001546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.